BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22130326)

  • 1. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
    Alloza I; Otaegui D; de Lapuente AL; Antigüedad A; Varadé J; Núñez C; Arroyo R; Urcelay E; Fernandez O; Leyva L; Fedetz M; Izquierdo G; Lucas M; Oliver-Martos B; Alcina A; Saiz A; Blanco Y; Comabella M; Montalban X; Olascoaga J; Matesanz F; Vandenbroeck K
    Genes Immun; 2012 Apr; 13(3):253-7. PubMed ID: 22130326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
    J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
    Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
    Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the
    Mena J; Alloza I; Tulloch Navarro R; Aldekoa A; Díez García J; Villanueva Etxebarria A; Lindskog C; Antigüedad A; Boyero S; Mendibe-Bilbao MDM; Álvarez de Arcaya A; Sánchez Menoyo JL; Midaglia L; Villarrubia N; Malhotra S; Montalban X; Villar LM; Comabella M; Vandenbroeck K
    Front Immunol; 2021; 12():816930. PubMed ID: 35111166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More CLEC16A gene variants associated with multiple sclerosis.
    Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
    Acta Neurol Scand; 2011 Jun; 123(6):400-6. PubMed ID: 20849399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis.
    Lopez de Lapuente A; Alloza I; Goertsches R; Zettl UK; Urcelay E; Arroyo R; Comabella M; Montalban X; Antigüedad A; Vandenbroeck K
    J Neuroimmunol; 2012 Apr; 245(1-2):98-101. PubMed ID: 22386267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and different genetic background for rheumatoid arthritis and coeliac disease.
    Coenen MJ; Trynka G; Heskamp S; Franke B; van Diemen CC; Smolonska J; van Leeuwen M; Brouwer E; Boezen MH; Postma DS; Platteel M; Zanen P; Lammers JW; Groen HJ; Mali WP; Mulder CJ; Tack GJ; Verbeek WH; Wolters VM; Houwen RH; Mearin ML; van Heel DA; Radstake TR; van Riel PL; Wijmenga C; Barrera P; Zhernakova A
    Hum Mol Genet; 2009 Nov; 18(21):4195-203. PubMed ID: 19648290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
    Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H
    J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
    Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility.
    Julià A; Ballina J; Cañete JD; Balsa A; Tornero-Molina J; Naranjo A; Alperi-López M; Erra A; Pascual-Salcedo D; Barceló P; Camps J; Marsal S
    Arthritis Rheum; 2008 Aug; 58(8):2275-86. PubMed ID: 18668548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis.
    Suzuki A; Kochi Y; Okada Y; Yamamoto K
    FEBS Lett; 2011 Dec; 585(23):3627-32. PubMed ID: 21600898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
    Al Jumah M; Al Balwi M; Hussein M; Kojan S; Al Khathaami A; Al Fawaz M; Al Muzaini B; Jawhary A; Al Abdulkareem I
    Mult Scler; 2012 Oct; 18(10):1395-400. PubMed ID: 22492128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients.
    Espino-Paisán L; De La Calle H; Fernández-Arquero M; Figueredo MA; De La Concha EG; Urcelay E; Santiago JL
    Autoimmunity; 2011 Dec; 44(8):624-30. PubMed ID: 21875375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia.
    Zoledziewska M; Costa G; Pitzalis M; Cocco E; Melis C; Moi L; Zavattari P; Murru R; Lampis R; Morelli L; Poddie F; Frongia P; Pusceddu P; Bajorek M; Marras A; Satta AM; Chessa A; Pugliatti M; Sotgiu S; Whalen MB; Rosati G; Cucca F; Marrosu MG
    Genes Immun; 2009 Jan; 10(1):15-7. PubMed ID: 18946483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis.
    Martín JE; Alizadeh BZ; González-Gay MA; Balsa A; Pascual-Salcedo D; Fernández-Gutiérrez B; Raya E; Franke L; van't Slot R; Coenen MJ; van Riel P; Radstake TR; Koeleman BP; Martín J
    Arthritis Rheum; 2010 Nov; 62(11):3183-90. PubMed ID: 20617525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association to the Glypican-5 gene in multiple sclerosis.
    Lorentzen AR; Melum E; Ellinghaus E; Smestad C; Mero IL; Aarseth JH; Myhr KM; Celius EG; Lie BA; Karlsen TH; Franke A; Harbo HF
    J Neuroimmunol; 2010 Sep; 226(1-2):194-7. PubMed ID: 20692050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of IL21 association with multiple sclerosis in a Swedish population.
    Lindén M; Nohra R; Sundqvist E; Khademi M; Hillert J; Alfredsson L; Olsson T; Kockum I
    Tissue Antigens; 2011 Oct; 78(4):271-4. PubMed ID: 21736561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
    Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; de las Heras V; Barcina MG; Arroyo R; Alcina A; Fernandez O; Antigüedad A; Urcelay E; Vandenbroeck K
    J Neuroimmunol; 2010 Jun; 223(1-2):100-3. PubMed ID: 20430450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.